Amena Deluca, MD
MOHS-Micrographic Surgery · Phoenix, AZNPI 1972766921
Payments from drug & device makers
Across 189 payments — averaging $29.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$749
- Sanofi$532
- Sun Pharmaceutical Industries Inc.$358
- Regeneron Healthcare Solutions, Inc.$350
- Galderma Laboratories, L.p.$307
- Incyte Corporation$303
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,538100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $749 |
| Sanofi | 16 | $532 |
| Sun Pharmaceutical Industries Inc. | 12 | $358 |
| Regeneron Healthcare Solutions, Inc. | 13 | $350 |
| Galderma Laboratories, L.p. | 7 | $307 |
| Incyte Corporation | 10 | $303 |
| Johnson & Johnson | 11 | $257 |
| Amgen | 5 | $210 |
| UCB, Inc. | 9 | $210 |
| Dermavant Sciences, Inc. | 9 | $207 |
| Revance Therapeutics, Inc. | 4 | $201 |
| Organon | 9 | $192 |
| Lilly USA, LLC | 8 | $171 |
| Almirall LLC | 4 | $170 |
| Merz North America, Inc. | 1 | $160 |
| Arcutis Biotherapeutics, Inc. | 7 | $156 |
| Pfizer | 4 | $142 |
| Argenx US, Inc. | 1 | $108 |
| Blueprint Medicines Corporation | 4 | $107 |
| E.r. Squibb & Sons, L.L.C. | 5 | $106 |
| Novartis | 3 | $95 |
| Organogenesis Inc. | 3 | $71 |
| Fidia Pharma USA Inc. | 3 | $64 |
| LEO Pharma Inc. | 2 | $47 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $35 |
| Verrica Pharmaceuticals Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Strata Skin Sciences, Inc. | 2 | $31 |
| Mimedx Group, Inc. | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| LNHC, Inc | 1 | $22 |
| Journey Medical Corporation | 1 | $14 |
| Biowound Solutions, Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,538 in reported general payments places this provider in the 80th percentile of 38 mohs-micrographic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 150 | $952 |
| ValacyclovirValacyclovir Hcl | 43 | $700 |
| Hydroxychloroquine Sulfate | 13 | $421 |
| Mupirocin | 50 | $345 |
| Clobetasol Propionate | 12 | $328 |
| Triamcinolone Acetonide | 20 | $172 |
| Doxycycline Hyclate | 17 | $154 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Phoenix
- John EbnerPhoenix$26K
- Yulia KhanPhoenix$3K
- James FosheePhoenix$1K
- Christine LinScottsdale$49K
- Joseph JanikChandler$8K
- J Ryan JacksonMesa$6K
- Seth GoodmanSun City$6K
- Mitchell ManwayScottsdale$6K
- Tejaswi MudigondaLake Havasu City$5K
- Christopher WeyerSierra Vista$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.